OMCL — OMNICELL, INC.

Nasdaq · Information Technology · Technology Hardware, Storage & Peripherals · CIK 926326 ·
Last close
$44.10
Market Cap
$2.01B
52W High
$46.89
52W Low
$31.75
ADV30
599,909
Next earnings
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026
Dec 2025 313,984,000 130,325,000 415,000 -2,026,000 1,974,720,000 196,520,000 742,906,000
Sep 2025 310,631,000 134,503,000 8,244,000 5,462,000 1,948,597,000 180,053,000 727,695,000
Jun 2025 290,562,000 127,678,000 8,120,000 5,639,000 2,145,496,000 399,004,000 881,877,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$127,300,000
Investing CF
$-60,363,000
Financing CF
$-218,317,000
CapEx
$-57,933,000
Dividends Paid
Buybacks
$-61,948,000
EPS Diluted TTM
$0.44
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$384,940,000
Inventory
$100,905,000
Receivables
$216,858,000
ST Investments
$14,648,000
EBIT TTM
$5,160,000
Pretax Income TTM
$11,325,000
Interest Exp TTM
Analysts
7

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,225,057,024
EBITDA
$73,610,000
Free Cash Flow
$112,564,376
Enterprise Value
$1,982,677,376
Total Cash
$239,220,992
Total Debt
$202,180,000
Shares Out
45,478,909
Trailing EPS
$0.44
Book Value
$27.36
ROE
1.6%
ROA
1.2%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,184,845,000 5,160,000 2,052,000 1,974,720,000 742,906,000 127,300,000
Dec 2024 1,112,238,000 337,000 12,531,000 2,120,960,000 877,647,000 187,722,000
Dec 2023 1,147,112,000 -34,868,000 -20,371,000 2,226,878,000 1,037,924,000 181,094,000
Dec 2022 1,295,947,000 -2,323,000 5,648,000 2,210,758,000 1,080,621,000 77,781,000

TTM Snapshot

Revenues TTM
$1,225,544,000
NetIncome TTM
$60,274,000
OpCashFlow TTM
$0
Assets (Latest)
$2,120,960,000
Forward EPS
$2.19

Peers — same industry

TickerNameMarket CapLastDaily %
DBD DIEBOLD NIXDORF, Inc $2.75B $79.43
NATL NCR Atleos Corp $3.33B $45.16
EVLV Evolv Technologies Holdings, Inc. $1.14B $6.35
VYX NCR Voyix Corp $910.91M $6.61
CRSR Corsair Gaming, Inc. $864.68M $8.09

News headlines (Yahoo Finance, 1h cache)

Omnicell Stock Surges 57.3% in a Year: What's Driving It?
2026-05-25 13:05 · Yahoo
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch
2026-05-23 19:32 · Yahoo
Should You Buy Omnicell (OMCL) After Golden Cross?
2026-05-22 13:55 · Yahoo
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
2026-05-20 14:40 · Yahoo
How Much Upside is Left in Omnicell (OMCL)? Wall Street Analysts Think 39.87%
2026-05-20 13:55 · Yahoo
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead
2026-05-17 01:24 · Yahoo
Here is What Analysts Are Saying About Omnicell, Inc. (OMCL)
2026-05-14 16:53 · Yahoo
Omnicell's (NASDAQ:OMCL) Soft Earnings Are Actually Better Than They Appear
2026-05-14 10:20 · Yahoo
3 Stocks Under $50 with Warning Signs
2026-05-14 01:08 · Yahoo
What Can You Expect From Omnicell Inc (OMCL) Stock After Solid Q1?
2026-05-12 18:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.